Your browser doesn't support javascript.
loading
Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant.
Fernández, Laura; Solana, Jose Carlos; Sánchez, Carmen; Jiménez, Mª Ángeles; Requena, Jose M; Coler, Rhea; Reed, Steven G; Valenzuela, Jesus G; Kamhawi, Shaden; Oliveira, Fabiano; Fichera, Epifanio; Glueck, Reinhard; Bottazzi, Maria Elena; Gupta, Gaurav; Cecilio, Pedro; Pérez-Cabezas, Begoña; Cordeiro-da-Silva, Anabela; Gradoni, Luigi; Carrillo, Eugenia; Moreno, Javier.
Affiliation
  • Fernández L; WHO Collaborating Centre for Leishmaniasis, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Madrid, Spain.
  • Solana JC; WHO Collaborating Centre for Leishmaniasis, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Madrid, Spain.
  • Sánchez C; WHO Collaborating Centre for Leishmaniasis, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Madrid, Spain.
  • Jiménez MÁ; Facultad de Veterinaria, Departamento de Medicina y Cirugía Animal, Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • Requena JM; Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Universidad Autónoma de Madrid, 28049 Madrid, Spain.
  • Coler R; Center for Global Infectious Disease Research (CGIDR), Seattle Children's Research Institute, Seattle, WA 98109, USA.
  • Reed SG; HDT Bio Corp, Seattle, WA 98102, USA.
  • Valenzuela JG; Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD 20852, USA.
  • Kamhawi S; Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD 20852, USA.
  • Oliveira F; Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD 20852, USA.
  • Fichera E; Etna Biotech S.R.L, 95121 Catania, Italy.
  • Glueck R; Etna Biotech S.R.L, 95121 Catania, Italy.
  • Bottazzi ME; Department of Pediatrics, Texas Children's Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
  • Gupta G; Etna Biotech S.R.L, 95121 Catania, Italy.
  • Cecilio P; Parasite Disease Group, Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 4200-135 Porto, Portugal.
  • Pérez-Cabezas B; IBMC-Instituto de Biologia Celular E Molecular, Universidade do Porto, 4150-180 Porto, Portugal.
  • Cordeiro-da-Silva A; Faculdade de Farmácia da, Universidade do Porto, 4099-002 Porto, Portugal.
  • Gradoni L; Parasite Disease Group, Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 4200-135 Porto, Portugal.
  • Carrillo E; IBMC-Instituto de Biologia Celular E Molecular, Universidade do Porto, 4150-180 Porto, Portugal.
  • Moreno J; Parasite Disease Group, Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, 4200-135 Porto, Portugal.
Microorganisms ; 9(11)2021 Oct 29.
Article in En | MEDLINE | ID: mdl-34835379
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Microorganisms Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Microorganisms Year: 2021 Document type: Article Affiliation country: Country of publication: